@aks4058
i think you're underestimating the dilution cost ( which is only 2/3rds done so far) and the fact the cornerstone wasnt wishing to fund LiFX further but wanted to exit. BUD is now a bloated issue base and so will tend to struggle post the deal period to attract higher alpha investors unless it shows really exceptional revenue growth
if i was a lt buyer i definitely wouldnt want debt until they can prove the uptick - youve just had 36+ months of proven missed expectation. it is folly to expect any change.
so that is what Im suggesting an investor (and board) should plan for - what should be hoped for is ofc something better
i take no joy in talking the counter case - but there are some obvious points of logic that need to be examined
- Forums
- ASX - By Stock
- BUD
- BUD-LifX The Future
BUD-LifX The Future, page-32
-
-
- There are more pages in this discussion • 208 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online